{"id":4129,"date":"2023-06-14T17:39:35","date_gmt":"2023-06-14T21:39:35","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=4129"},"modified":"2026-04-13T14:56:03","modified_gmt":"2026-04-13T18:56:03","slug":"unleashing-the-power-of-aptamers-an-alternative-to-antibodies","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/","title":{"rendered":"Unleashing the Power of Aptamers: An Alternative to Antibodies"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-4130 aligncenter\" src=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1-300x164.png\" alt=\"\" width=\"382\" height=\"209\" srcset=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1-300x164.png 300w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png 512w\" sizes=\"(max-width: 382px) 100vw, 382px\" \/><\/p>\n<p>Dans le monde de la reconnaissance mol\u00e9culaire et des th\u00e9rapies cibl\u00e9es, les aptam\u00e8res ont \u00e9merg\u00e9 comme une alternative aux anticorps. Ces mol\u00e9cules d'acides nucl\u00e9iques poss\u00e8dent un ensemble remarquable de caract\u00e9ristiques qui les rendent tr\u00e8s souhaitables dans divers domaines, notamment les diagnostics, la th\u00e9rapeutique et le d\u00e9veloppement de m\u00e9dicaments. Les aptam\u00e8res pr\u00e9sentent une sp\u00e9cificit\u00e9 et une affinit\u00e9 exceptionnelles envers leurs mol\u00e9cules cibles, d\u00e9passant parfois les anticorps. Ils offrent \u00e9galement des avantages tels qu'une faible immunog\u00e9nicit\u00e9, une synth\u00e8se et une modification faciles, ainsi qu'une identification rapide des cibles.<\/p>\n<p>R\u00e9cemment, nous vous avons demand\u00e9 quelle \u00e9tait, selon vous, le plus grand avantage de l'utilisation des aptam\u00e8res par rapport \u00e0 d'autres biomol\u00e9cules dans la recherche et les applications. Dans ce blog, nous explorerons quelques raisons pour lesquelles les aptam\u00e8res sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme une excellente alternative aux anticorps, examinant comment ces avantages contribuent \u00e0 leur efficacit\u00e9 et \u00e0 leur polyvalence. En plongeant dans les attributs des aptam\u00e8res, nous d\u00e9couvrirons leur immense potentiel pour r\u00e9volutionner la reconnaissance mol\u00e9culaire et ouvrir la voie \u00e0 de nouvelles applications dans la recherche m\u00e9dicale, les diagnostics et la th\u00e9rapeutique cibl\u00e9e.<\/p>\n<h2><\/h2>\n<h2><strong>Haute Sp\u00e9cificit\u00e9 et Affinit\u00e9<\/strong><\/h2>\n<p>Compar\u00e9s aux anticorps, les aptam\u00e8res pr\u00e9sentent plusieurs avantages en termes de sp\u00e9cificit\u00e9 et d'affinit\u00e9. Tout d'abord, les aptam\u00e8res peuvent \u00eatre g\u00e9n\u00e9r\u00e9s contre une large gamme de mol\u00e9cules cibles, notamment des prot\u00e9ines, des petites mol\u00e9cules et m\u00eame des cellules enti\u00e8res. Cette polyvalence permet le d\u00e9veloppement d'aptam\u00e8res pour diverses applications dans diff\u00e9rents domaines. Deuxi\u00e8mement, les aptam\u00e8res peuvent atteindre une haute sp\u00e9cificit\u00e9 gr\u00e2ce \u00e0 des processus de s\u00e9lection intelligemment con\u00e7us. Chez NeoVentures, nous avons cr\u00e9\u00e9 une plateforme de s\u00e9lection de nouvelle g\u00e9n\u00e9ration qui permet d'augmenter la sp\u00e9cificit\u00e9 et la s\u00e9lectivit\u00e9 lors de la cr\u00e9ation d'aptam\u00e8res. Ce processus permet l'identification d'aptam\u00e8res capables de reconna\u00eetre et de se lier sp\u00e9cifiquement \u00e0 leur cible avec une pr\u00e9cision exceptionnelle. Pour certaines mol\u00e9cules cibles, les aptam\u00e8res peuvent pr\u00e9senter des constantes d'affinit\u00e9 comparables, voire sup\u00e9rieures \u00e0 celles des anticorps, garantissant une liaison robuste et efficace \u00e0 la cible. Les avantages d'une haute sp\u00e9cificit\u00e9 et d'une grande affinit\u00e9 des aptam\u00e8res en font des outils inestimables dans diverses applications, telles que les diagnostics, la th\u00e9rapeutique et la d\u00e9livrance cibl\u00e9e de m\u00e9dicaments, o\u00f9 la reconnaissance mol\u00e9culaire pr\u00e9cise et efficace est d'une importance capitale.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Faible Immunog\u00e9nicit\u00e9 <\/strong><\/h2>\n<p>L'un des avantages significatifs des aptam\u00e8res par rapport aux anticorps r\u00e9side dans leur faible immunog\u00e9nicit\u00e9. Contrairement aux anticorps, qui peuvent entra\u00eener la formation d'anticorps antidrogue, les aptam\u00e8res ont une probabilit\u00e9 r\u00e9duite d'induire une telle r\u00e9ponse immunog\u00e8ne. Cela s'explique par le fait que les aptam\u00e8res sont des mol\u00e9cules d'acides nucl\u00e9iques qui ne poss\u00e8dent pas de nature prot\u00e9ique. Ce profil de faible immunog\u00e9nicit\u00e9 rend les aptam\u00e8res attrayants pour diverses applications, en particulier dans le domaine th\u00e9rapeutique. Cette caract\u00e9ristique est particuli\u00e8rement avantageuse pour l'administration r\u00e9p\u00e9t\u00e9e de m\u00e9dicaments ou de th\u00e9rapies \u00e0 base d'aptam\u00e8res, car elle minimise le risque de neutralisation de l'effet th\u00e9rapeutique ou d'apparition d'effets ind\u00e9sirables chez les patients. De plus, la faible immunog\u00e9nicit\u00e9 des aptam\u00e8res simplifie leur production et r\u00e9duit la n\u00e9cessit\u00e9 de modifications ou d'ing\u00e9nierie suppl\u00e9mentaires pour att\u00e9nuer les r\u00e9ponses immunitaires potentielles, ce qui permet de rationaliser le d\u00e9veloppement et l'application des technologies \u00e0 base d'aptam\u00e8res.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Facilit\u00e9 de Synth\u00e8se et de Modification<\/strong><\/h2>\n<p>Cette option a \u00e9t\u00e9 le choix le plus populaire parmi nos abonn\u00e9s. Les aptam\u00e8res offrent des avantages distincts en termes de synth\u00e8se et de modification par rapport aux anticorps. Les aptam\u00e8res peuvent \u00eatre synth\u00e9tis\u00e9s chimiquement \u00e0 l'aide de techniques bien \u00e9tablies et \u00e9volutives, ce qui permet une production rapide et rentable. En revanche, la production d'anticorps n\u00e9cessite souvent des processus complexes et chronophages, tels que l'immunisation et la technologie des hybridomes, qui peuvent \u00eatre co\u00fbteux et difficiles \u00e0 mettre \u00e0 l'\u00e9chelle. De plus, les aptam\u00e8res peuvent \u00eatre facilement modifi\u00e9s pendant leur synth\u00e8se ou apr\u00e8s leur synth\u00e8se gr\u00e2ce \u00e0 la conjugaison chimique, ce qui permet d'introduire divers groupes fonctionnels ou \u00e9tiquettes \u00e0 des fins sp\u00e9cifiques. Cette flexibilit\u00e9 permet d'incorporer des \u00e9tiquettes pour la d\u00e9tection ou l'imagerie, de les fixer \u00e0 des supports solides pour l'immobilisation ou de les conjuguer \u00e0 des agents th\u00e9rapeutiques pour une administration cibl\u00e9e. Les aptam\u00e8res peuvent tol\u00e9rer des modifications chimiques sans perdre leurs propri\u00e9t\u00e9s de liaison, ce qui les rend tr\u00e8s adaptables et personnalisables pour des applications sp\u00e9cifiques. La facilit\u00e9 de synth\u00e8se et de modification offre aux chercheurs et aux d\u00e9veloppeurs une bo\u00eete \u00e0 outils polyvalente pour adapter les aptam\u00e8res \u00e0 des besoins sp\u00e9cifiques en mati\u00e8re de diagnostics, de th\u00e9rapeutiques et de biosenseurs, entre autres domaines.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Identification Rapide de Cibles<\/strong><\/h2>\n<p>Les aptam\u00e8res offrent un avantage significatif par rapport aux anticorps en ce qui concerne le d\u00e9veloppement rapide pour une cible. Le processus de s\u00e9lection des aptam\u00e8res \u00e0 l'aide de la m\u00e9thode de s\u00e9lection Neomer est termin\u00e9 en une semaine. Cela permet l'identification rapide d'aptam\u00e8res qui se lient sp\u00e9cifiquement \u00e0 une mol\u00e9cule cible souhait\u00e9e. En revanche, le d\u00e9veloppement d'anticorps n\u00e9cessite g\u00e9n\u00e9ralement l'immunisation d'animaux, suivi d'une s\u00e9rie d'\u00e9tapes de d\u00e9pistage et de caract\u00e9risation qui peuvent prendre plusieurs mois \u00e0 terminer. La capacit\u00e9 d'identification rapide de la cible des aptam\u00e8res est particuli\u00e8rement avantageuse dans des applications sensibles au temps, telles que les diagnostics ou les sc\u00e9narios d'intervention d'urgence, o\u00f9 une identification rapide et pr\u00e9cise est cruciale. De plus, la capacit\u00e9 de g\u00e9n\u00e9rer rapidement des aptam\u00e8res contre une large gamme de cibles am\u00e9liore la polyvalence et l'adaptabilit\u00e9 dans divers contextes de recherche et industriels. La rapidit\u00e9 et l'efficacit\u00e9 de la s\u00e9lection des aptam\u00e8res acc\u00e9l\u00e8rent le d\u00e9veloppement de nouvelles technologies bas\u00e9es sur les aptam\u00e8res et facilitent leur translation dans des applications pratiques.<\/p>\n<p>En conclusion, les aptam\u00e8res constituent une alternative convaincante aux anticorps, offrant de nombreux avantages dans plusieurs domaines fondamentaux. Leur grande sp\u00e9cificit\u00e9 et affinit\u00e9 permettent une reconnaissance mol\u00e9culaire pr\u00e9cise, rivalisant ou surpassant les anticorps en termes de capacit\u00e9s de liaison \u00e0 la cible. La faible immunog\u00e9nicit\u00e9 des aptam\u00e8res minimise le risque de r\u00e9ponses immunitaires, les rendant adapt\u00e9s \u00e0 une administration r\u00e9p\u00e9t\u00e9e et r\u00e9duisant la n\u00e9cessit\u00e9 de modifications pour att\u00e9nuer les pr\u00e9occupations li\u00e9es \u00e0 l'immunog\u00e9nicit\u00e9. De plus, la facilit\u00e9 de synth\u00e8se et de modification donne aux chercheurs un ensemble d'outils polyvalent, permettant une production rapide et une personnalisation pour des applications sp\u00e9cifiques. De plus, le processus de s\u00e9lection des aptam\u00e8res permet une identification rapide, facilitant les applications sensibles au temps. Dans l'ensemble, les aptam\u00e8res offrent une solution convaincante combinant sp\u00e9cificit\u00e9, affinit\u00e9, faible immunog\u00e9nicit\u00e9, facilit\u00e9 de synth\u00e8se et identification rapide de la cible, les positionnant comme un outil puissant et prometteur pour divers domaines, notamment les diagnostics, les th\u00e9rapeutiques et la recherche biotechnologique. Avec leurs attributs remarquables, les aptam\u00e8res ont un immense potentiel pour faire avancer la d\u00e9couverte scientifique et d\u00e9velopper des solutions innovantes pour r\u00e9soudre des d\u00e9fis complexes.<\/p>\n<p>Alors, dans ce cas, nous pensons que toutes les options ci-dessus \u00e9taient la meilleure r\u00e9ponse ! Souhaitez-vous discuter davantage avec nous ? Contactez-nous directement. <a href=\"https:\/\/neoaptamers.com\/fr\/contact-us\/\">here.<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>In the world of molecular recognition and targeted therapies, aptamers have emerged as an alternative to antibodies. These nucleic acid molecules possess a remarkable set of characteristics that make them highly desirable in various fields, including diagnostics, therapeutics, and drug development. Aptamers exhibit exceptional specificity and affinity towards their target molecules, surpassing antibodies in some&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Unleashing the Power of Aptamers: An Alternative to Antibodies<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4130,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-4129","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Unleashing the Power of Aptamers: An Alternative to Antibodies<\/title>\n<meta name=\"description\" content=\"An alternative to antibodies, the power of aptamers are they exhibit exceptional specificity and affinity towards their target molecules.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unleashing the Power of Aptamers: An Alternative to Antibodies\" \/>\n<meta property=\"og:description\" content=\"An alternative to antibodies, the power of aptamers are they exhibit exceptional specificity and affinity towards their target molecules.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-14T21:39:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T18:56:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"512\" \/>\n\t<meta property=\"og:image:height\" content=\"280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Unleashing the Power of Aptamers: An Alternative to Antibodies\",\"datePublished\":\"2023-06-14T21:39:35+00:00\",\"dateModified\":\"2026-04-13T18:56:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/\"},\"wordCount\":950,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Picture1.png\",\"articleSection\":[\"Aptamers\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/\",\"name\":\"Unleashing the Power of Aptamers: An Alternative to Antibodies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Picture1.png\",\"datePublished\":\"2023-06-14T21:39:35+00:00\",\"dateModified\":\"2026-04-13T18:56:03+00:00\",\"description\":\"An alternative to antibodies, the power of aptamers are they exhibit exceptional specificity and affinity towards their target molecules.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Picture1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Picture1.png\",\"width\":512,\"height\":280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Unleashing the Power of Aptamers: An Alternative to Antibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unleashing the Power of Aptamers: An Alternative to Antibodies","description":"An alternative to antibodies, the power of aptamers are they exhibit exceptional specificity and affinity towards their target molecules.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/","og_locale":"fr_FR","og_type":"article","og_title":"Unleashing the Power of Aptamers: An Alternative to Antibodies","og_description":"An alternative to antibodies, the power of aptamers are they exhibit exceptional specificity and affinity towards their target molecules.","og_url":"https:\/\/neoaptamers.com\/fr\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/","og_site_name":"neoaptamers","article_published_time":"2023-06-14T21:39:35+00:00","article_modified_time":"2026-04-13T18:56:03+00:00","og_image":[{"width":512,"height":280,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Unleashing the Power of Aptamers: An Alternative to Antibodies","datePublished":"2023-06-14T21:39:35+00:00","dateModified":"2026-04-13T18:56:03+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/"},"wordCount":950,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png","articleSection":["Aptamers"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/","url":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/","name":"Unleashing the Power of Aptamers: An Alternative to Antibodies","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png","datePublished":"2023-06-14T21:39:35+00:00","dateModified":"2026-04-13T18:56:03+00:00","description":"An alternative to antibodies, the power of aptamers are they exhibit exceptional specificity and affinity towards their target molecules.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/06\/Picture1.png","width":512,"height":280},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/unleashing-the-power-of-aptamers-an-alternative-to-antibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Unleashing the Power of Aptamers: An Alternative to Antibodies"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=4129"}],"version-history":[{"count":3,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4129\/revisions"}],"predecessor-version":[{"id":6511,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4129\/revisions\/6511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/4130"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=4129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=4129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=4129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}